Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 11 studies | 35% ± 21% | |
epithelial cell | 5 studies | 30% ± 8% | |
secretory cell | 4 studies | 36% ± 12% | |
keratinocyte | 4 studies | 43% ± 19% | |
club cell | 3 studies | 34% ± 15% | |
ciliated cell | 3 studies | 35% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 40% | 8297.41 | 576 / 1445 | 73% | 262.41 | 133 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.05 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 96% | 366.54 | 43 / 45 |
intestine | 33% | 613.38 | 322 / 966 | 50% | 27.58 | 263 / 527 |
skin | 71% | 2965.24 | 1287 / 1809 | 9% | 9.16 | 41 / 472 |
lung | 23% | 161.96 | 132 / 578 | 54% | 117.01 | 622 / 1155 |
uterus | 4% | 255.61 | 6 / 170 | 61% | 277.45 | 280 / 459 |
bladder | 0% | 0 | 0 / 21 | 41% | 86.05 | 207 / 504 |
pancreas | 0% | 0 | 0 / 328 | 37% | 29.44 | 66 / 178 |
stomach | 5% | 45.86 | 18 / 359 | 26% | 13.94 | 73 / 286 |
thymus | 1% | 3.04 | 5 / 653 | 22% | 18.95 | 131 / 605 |
breast | 4% | 24.26 | 20 / 459 | 6% | 5.26 | 68 / 1118 |
ovary | 0% | 0 | 0 / 180 | 10% | 3.71 | 43 / 430 |
prostate | 6% | 67.84 | 15 / 245 | 4% | 1.38 | 18 / 502 |
kidney | 1% | 3.30 | 1 / 89 | 2% | 0.65 | 19 / 901 |
adipose | 1% | 6.94 | 12 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.20 | 2 / 406 |
muscle | 0% | 2.03 | 2 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 4.82 | 2 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 3.24 | 2 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.44 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 0% | 0 | 0 / 705 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0090050 | Biological process | positive regulation of cell migration involved in sprouting angiogenesis |
GO_0007165 | Biological process | signal transduction |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0045743 | Biological process | positive regulation of fibroblast growth factor receptor signaling pathway |
GO_0051450 | Biological process | myoblast proliferation |
GO_1903589 | Biological process | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO_2000288 | Biological process | positive regulation of myoblast proliferation |
GO_0007267 | Biological process | cell-cell signaling |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0009986 | Cellular component | cell surface |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0008201 | Molecular function | heparin binding |
GO_0017134 | Molecular function | fibroblast growth factor binding |
GO_0005515 | Molecular function | protein binding |
GO_0019838 | Molecular function | growth factor binding |
Gene name | FGFBP1 |
Protein name | Fibroblast growth factor-binding protein 1 (FGF-BP) (FGF-BP1) (FGF-binding protein 1) (FGFBP-1) (17 kDa heparin-binding growth factor-binding protein) (17 kDa HBGF-binding protein) (HBp17) |
Synonyms | FGFBP HBP17 |
Description | FUNCTION: Acts as a carrier protein that release fibroblast-binding factors (FGFs) from the extracellular matrix (EM) storage and thus enhance the mitogenic activity of FGFs. Enhances FGF2 signaling during tissue repair, angiogenesis and in tumor growth. . |
Accessions | Q14512 ENST00000382333.2 |